EHC
Encompass Health CorporationNYSEHealthcare$97.39+0.01%ClosedMarket Cap: $9.80B
As of 2026-04-06
Valuation
P/E (TTM)
17.31
PEG
0.71
P/B
4.00
P/S
1.65
EV/EBITDA
8.84
DCF Value
$43.88
FCF Yield
4.5%
Div Yield
0.8%
Margins & Returns
Gross Margin
38.8%
Operating Margin
17.7%
Net Margin
9.5%
ROE
24.5%
ROA
10.4%
ROIC
13.3%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $1.54B | 22.8% | $283.4M | $146.1M | $1.44 | $0.19 |
| FY 2025 | $5.94B | 21.7% | $1.05B | $566.2M | $5.55 | $0.70 |
| Q3 2025 | $1.48B | 46.9% | $243.6M | $126.5M | $1.24 | $0.17 |
| Q2 2025 | $1.46B | 43.0% | $259.1M | $142.1M | $1.39 | $0.17 |
| Q1 2025 | $1.46B | 43.3% | $267.0M | $151.5M | $1.48 | $0.17 |
| Q4 2024 | $1.41B | 41.7% | $232.3M | $120.9M | $1.18 | $0.17 |
| FY 2024 | $5.37B | 41.6% | $864.5M | $455.7M | $4.46 | $0.62 |
| Q3 2024 | $1.35B | 41.3% | $209.1M | $108.2M | $1.06 | $0.15 |
| Q2 2024 | $1.30B | 41.7% | $215.6M | $114.1M | $1.12 | $0.15 |
| Q1 2024 | $1.32B | 41.5% | $207.5M | $112.5M | $1.10 | $0.30 |
| Q4 2023 | $1.25B | 41.1% | $444.8M | $87.6M | $0.86 | $0.30 |
| FY 2023 | $4.80B | 41.3% | $1.72B | $352.0M | $3.47 | $0.75 |